2023 Middle East MNO Directory: Covering 41+ Operators From
Dublin, May 10, 2023 (GLOBE NEWSWIRE) -- The "Middle East MNO Directory 2023-2024" directory has been added to ResearchAndMarkets.com's offering. This...
Source: globenewswire.com
Page 38 - Group Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Group Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Group Information Today - Breaking & Trending Today
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis
These 2 randomized clinical trials compare the efficacy and safety of 2 doses of the autotaxin inhibitor ziritaxestat vs placebo in patients with idiopathic pul
Source: jamanetwork.com
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials | Critical Care Medicine | JAMA
These 2 randomized clinical trials compare the efficacy and safety of renin-angiotensin system (RAS) modulation using 2 investigational RAS agents, TXA-127 vs p
Source: jamanetwork.com
Castelnau Group Ltd - Annual Report & Audited Financial Statements 2022
Castelnau Group Limited Annual Report and Audited Consolidated Financial Statements 2022 LEI: 213800PED8RFUBMK1T64 The Company has today, in accordance with DTR 6.3.5, released its Annual... | April 4, 2023
Source: marketscreener.com
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
This exploratory study of a multiplatform randomized trial investigating the effects of therapeutic-dose heparin in early-pandemic hospitalized COVID-19 patient
Source: jamanetwork.com